ZA984433B - Use of low-molecular-weight heparins for the prevention and treatment of cerebral oedemas - Google Patents

Use of low-molecular-weight heparins for the prevention and treatment of cerebral oedemas

Info

Publication number
ZA984433B
ZA984433B ZA984433A ZA984433A ZA984433B ZA 984433 B ZA984433 B ZA 984433B ZA 984433 A ZA984433 A ZA 984433A ZA 984433 A ZA984433 A ZA 984433A ZA 984433 B ZA984433 B ZA 984433B
Authority
ZA
South Africa
Prior art keywords
prevention
molecular
treatment
low
weight heparins
Prior art date
Application number
ZA984433A
Other languages
English (en)
Inventor
Veronique Mary
Jeremy Pratt
Jean-Marie Stutzmann
Andre Uzan
Florence Wahl
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of ZA984433B publication Critical patent/ZA984433B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
ZA984433A 1997-05-28 1998-05-25 Use of low-molecular-weight heparins for the prevention and treatment of cerebral oedemas ZA984433B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9706551A FR2763849B1 (fr) 1997-05-28 1997-05-28 Utilisation des heparines de bas poids moleculaire pour la prevention et le traitement des oedemes cerebraux

Publications (1)

Publication Number Publication Date
ZA984433B true ZA984433B (en) 1998-12-28

Family

ID=9507336

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA984433A ZA984433B (en) 1997-05-28 1998-05-25 Use of low-molecular-weight heparins for the prevention and treatment of cerebral oedemas

Country Status (24)

Country Link
US (1) US6579858B1 (ko)
EP (1) EP0984787B1 (ko)
JP (1) JP2002502387A (ko)
KR (1) KR100562425B1 (ko)
CN (1) CN1223351C (ko)
AT (1) ATE225181T1 (ko)
AU (1) AU742995B2 (ko)
BR (1) BR9809180A (ko)
CA (1) CA2290682A1 (ko)
DE (1) DE69808455T2 (ko)
DK (1) DK0984787T3 (ko)
ES (1) ES2182321T3 (ko)
FR (1) FR2763849B1 (ko)
IL (2) IL132670A0 (ko)
MA (1) MA24554A1 (ko)
NO (1) NO317003B1 (ko)
NZ (1) NZ501366A (ko)
PE (1) PE73099A1 (ko)
PT (1) PT984787E (ko)
RU (1) RU2195287C2 (ko)
TN (1) TNSN98072A1 (ko)
TW (1) TW546141B (ko)
WO (1) WO1998053834A1 (ko)
ZA (1) ZA984433B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2787329B1 (fr) * 1998-12-17 2001-02-09 Aventis Pharma Sa Nouvelle application therapeutique des heparines de bas poids moleculaire
WO2003018032A1 (en) * 2001-08-28 2003-03-06 Leo Pharma A/S Antithrombotic compositions comprising low molecular weight heparin and low molecular weight dermatan sulphate
RU2238737C1 (ru) * 2003-04-17 2004-10-27 Закрытое Акционерное Общество Научно-Производственный Центр "Борщаговский Химико-Фармацевтический Завод" Препарат "веногепанол" для лечения и профилактики патологических поражений сосудов и тканей
ITMI20031023A1 (it) * 2003-05-21 2004-11-22 Umberto Cornelli Glicosaminoglicani aventi peso molecolare medio 2400 d atti al trattamento delle disfunzioni emozionali.
US11840565B2 (en) 2016-12-29 2023-12-12 University Of Miami Methods and compositions for treating virus-associated inflammation
SG11202013176VA (en) 2018-07-03 2021-01-28 Univ Miami Compositions and methods for treating inflammasome related diseases or conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2013092C1 (ru) * 1989-02-27 1994-05-30 Дагестанский государственный медицинский институт Способ лечения отека мозга при туберкулезном менингоэнцефалите

Also Published As

Publication number Publication date
IL132670A (en) 2010-05-31
TNSN98072A1 (fr) 2005-03-15
EP0984787B1 (fr) 2002-10-02
DK0984787T3 (da) 2003-02-03
JP2002502387A (ja) 2002-01-22
FR2763849A1 (fr) 1998-12-04
US6579858B1 (en) 2003-06-17
CN1257429A (zh) 2000-06-21
RU2195287C2 (ru) 2002-12-27
KR20010013073A (ko) 2001-02-26
FR2763849B1 (fr) 2000-09-15
PE73099A1 (es) 1999-10-21
ATE225181T1 (de) 2002-10-15
IL132670A0 (en) 2001-03-19
KR100562425B1 (ko) 2006-03-17
DE69808455D1 (de) 2002-11-07
CA2290682A1 (fr) 1998-12-03
BR9809180A (pt) 2000-08-01
AU7776098A (en) 1998-12-30
ES2182321T3 (es) 2003-03-01
NZ501366A (en) 2000-11-24
NO317003B1 (no) 2004-07-19
WO1998053834A1 (fr) 1998-12-03
EP0984787A1 (fr) 2000-03-15
TW546141B (en) 2003-08-11
DE69808455T2 (de) 2003-07-03
NO995539D0 (no) 1999-11-12
NO995539L (no) 1999-11-12
PT984787E (pt) 2003-01-31
AU742995B2 (en) 2002-01-17
MA24554A1 (fr) 1998-12-31
CN1223351C (zh) 2005-10-19

Similar Documents

Publication Publication Date Title
IL108114A0 (en) Therapeutic potentiated interferon combination
AU7625196A (en) Bandaging system
PL310476A1 (en) Application of lamotrigin in treating neuro-aids diseases
MX9703693A (es) Tratamiento profilactico de dermatitis alergica por contacto.
CA2156481A1 (en) 5-ht2 receptor antagonist compositions useful in treating venous conditions
ZA984433B (en) Use of low-molecular-weight heparins for the prevention and treatment of cerebral oedemas
SE9601395D0 (sv) New therapeutic treatment 1
AU4726797A (en) Prophylactic/remedial agent
ZA971600B (en) Treatment of macular edema.
AU2196297A (en) Methods of treating or preventing interstitial cystitis
NZ501365A (en) Use of low-molecular-weight heparins for preventing and treating central nervous system (CNS) trauma
LV11593A (lv) Dimetikona pielietojums aizcietejumu arstesana
WO1994018988A3 (en) Use of heparins for the treatment of inflammatory or immunological diseases
NZ302670A (en) Use of 2,3-dihydro-imidazo[2,1-b]benzothiazole derivatives to treat degenerative disorders and ageing of the nervous and vascular systems
IL143279A0 (en) Novel therapeutic application of low molecular weight heparin
ZA9610073B (en) Method of using beta-interferons to treat restenosis
WO1998025594A3 (en) Lamotrigine in the treatment and prophylaxis of migraine
IL126157A0 (en) Method for treating excessive aggression
UA12972A (uk) Спосіб лікуваhhя тромбозів та тромбоемболій
EA199800818A1 (ru) Способ лечения бессонницы
BA95039A (bs) Set za prevenciju i terapiju bolne menstruacije
BG98003U (en) Medicament for the treatment of dermatomycosis
BG98001U (en) Medicament for the treatment of hyperkeratotic conditions of the skin
GB9605642D0 (en) Treatment of macular edema
UA8280A (uk) Спосіб лікування псоріазу